Status:
RECRUITING
Comparison of the Performances of the cTOFR and the mTOFR During Reversal of Deep Neuromuscular Blockade With Sugammadex
Lead Sponsor:
Ankara University
Conditions:
Neuromuscular Blockade
Anesthesia, General
Eligibility:
All Genders
18-65 years
Brief Summary
It is known that deep neuromuscular block improves surgical conditions, especially during laparoscopic abdominal surgery. Based on this, in the Perioperative Neuromuscular Blockade Management guide pu...
Detailed Description
Neuromuscular blockers (NMB) agents are commonly used drugs in anesthesia for facilitating airway management, improving surgical conditions, and inducing immobility in critical situations. As a natura...
Eligibility Criteria
Inclusion
- Age: 18 - 65 (not including 65)
- BMI: 18.5-24.9
Exclusion
- Liver and kidney disease
- Non-consenting
- Emergency surgeries
- Muscle disease
- Allergy to rocuronium and sugammadex
- Patients predicted to have difficult mask ventilation or difficult intubation
- Pregnant and breastfeeding women
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
199 Patients enrolled
Trial Details
Trial ID
NCT06220136
Start Date
June 1 2024
End Date
December 1 2024
Last Update
June 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara University
Ankara, Altındağ, Turkey (Türkiye), 06230